Clinical trial

Proprotein Convertase Subtilisin Kexin 9 in Rheumatoid Arthritis

NCT05191342

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2021-11-01

PhaseN/A

Study timeline

Study start (actual)2021-11-01Date precision: day

Registry last updated2022-01-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

PCSK9unresolved

Interventions

Enzyme-linked immunosorbent assay for PCSK9DIAGNOSTIC_TEST

Sponsors & collaborators

First Affiliated Hospital of Harbin Medical Universitylead sponsor

Mapped research locations

HarbinHeilongjiang, China2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05191342 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.